ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
x/twitter facebook linkedin bluesky youtube instagram iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home Meeting News

Pathology Researcher Keith Kerr Receives 2025 Heine H. Hansen Award

Nathan Pettengill
on: April 08, 2025In: Meeting News, Names & News, Society News
Pathology Researcher Keith Kerr Receives 2025 Heine H. Hansen Award

During his award lecture at the European Lung Cancer Congress, Dr. Kerr said lung cancer treatment has benefited from the bridging of the historical divide between pathology and medical oncology. Read more


Combination Therapies as Frontline Treatment for EGFR-Mutated NSCLC: Are the Rewards Worth the Risks?

Haleigh Behrman
on: March 25, 2025In: Evolving Standards of Care, Meeting News, Names & News
Combination Therapies as Frontline Treatment for EGFR-Mutated NSCLC: Are the Rewards Worth the Risks?

During a TTLC debate, Drs. Helena Yu and Shirish Gadgeel weighed the pros and limitations of osimertinib monotherapy and combination therapies. Read more

With Data on Her Side, Dr. Anne Tsao Dominates Debate on Merits of Chemo-IO for Mesothelioma

Haleigh Behrman
on: March 25, 2025In: Evolving Standards of Care, Meeting News, Names & News
With Data on Her Side, Dr. Anne Tsao Dominates Debate on Merits of Chemo-IO for Mesothelioma

Lacking evidence to argue against combinations in this patient population, Dr. Penelope Bradbury, turned to humor to make her case. Read more

Will Bispecific Antibodies Replace PD-(L)1 Targeted Agents?

Nathan Pettengill
on: March 11, 2025In: Meeting News, Names & News, Society News
Will Bispecific Antibodies Replace PD-(L)1 Targeted Agents?

Drs. Jonathan W. Riess and Greg Kalemkerian present opposing views regarding the therapeutic potential of novel targeted therapies. Read more

Debate Leaves Audience Unconvinced that KRAS Inhibitors Deserve Promotion to First-Line Treatment

Nathan Pettengill
on: March 11, 2025In: Meeting News, Names & News, Society News
Debate Leaves Audience Unconvinced that KRAS Inhibitors Deserve Promotion to First-Line Treatment

While Dr. Trever Bivona argued that KRAS inhibitors will join other seminal oncogene inhibitors, Dr. Rebecca Heist said the data has yet to demonstrate they outperform the current second-line standard of care. Read more

Where There’s Smoke: The Global Threat of Lung Cancer in Patients with No Smoking History and its Implications in Screening

Haleigh Behrman
on: February 25, 2025In: Meeting News, Risk Assessment and Reduction, Screening/ED
Where There’s Smoke: The Global Threat of Lung Cancer in Patients with No Smoking History and its Implications in Screening

Dr. Lucia Viola says that access to genomic profiling is crucial for gathering information about patients who do not smoke. Read more

Study Finds Correlations Between Certain Factors, Rates of Nodal Upstaging

Haleigh Behrman
on: February 25, 2025In: Meeting News, Risk Assessment and Reduction, Surgical Oncology
Study Finds Correlations Between Certain Factors, Rates of Nodal Upstaging

Dr. Stella Martinez recently shared the latest data and explored the challenges and opportunities in lung cancer surgery in Latin America. Read more

Experts Share New Insights, Key Updates During Final Plenary Session of the 2024 ACLC

Haleigh Behrman
on: January 21, 2025In: Global Initiatives, Meeting News, Society News
Experts Share New Insights, Key Updates During Final Plenary Session of the 2024 ACLC

Takeaways included updates from the CheckMate 816 study, advances in technology, the role of metabolites and mobile CT screening in predicting cancer risk, and the importance of biomarkers for guiding optimal treatment. Read more

Future Directions in Lung Cancer Treatment

Haleigh Behrman
on: January 07, 2025In: Global Initiatives, Meeting News, Society News
Future Directions in Lung Cancer Treatment

During the opening plenary session at the 2024 Asia Conference on Lung Cancer, experts offered their perspectives on clinical trials, combination therapies, and research initiatives. Read more

BR.31 Trial Falls Short of DFS Primary Endpoint

Haleigh Behrman
on: December 17, 2024In: Meeting News, Society News
BR.31 Trial Falls Short of DFS Primary Endpoint

Prof. Glenwood Goss said adjuvant durvalumab did not improve disease-free survival outcomes following complete resection and optional chemotherapy. Read more

‹12345›»

SEARCH ILCN

Archives

PROVIDER RESOURCES

MARIPOSA OS Data Confirms Improved Efficacy for Amivantamab Plus Lazertinib in the First Line for EGFR-mutated NSCLC

INDUSTRY SUPPORTED


COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events

INDUSTRY SUPPORTED

POPULAR ARTICLES

Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2024 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy